Document is current
Any future updates will be listed below
-
Authors
Chen, Chuxin
Wang, Ning
Zhang, Xueyan
Fu, Yingjie
Zhong, Zhiyong
Wu, Haibin
Wei, Yaming
Duan, Yuyou https://orcid.org/0000-0002-1402-7402
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2018YFA0108200)
National Key Research and Development Program of China (2018YFA0108201)
National Key Research and Development Program of China (2018YFA0108204)
Research Starting Funding of South China University of Technology (D6201880)
Research Starting Funding of South China University of Technology (K5180910)
Research Starting Funding of South China University of Technology (K5204120)
Research Starting Funding of South China University of Technology (D6212440)
Research Starting Funding of the Second Affiliated Hospital of South China University of Technology (KY09060026)
Research Agreement between South China University of Technology and Guangzhou First People’s Hospital (D9194290)
Key Clinical Technology Program of Guangzhou (2019ZD18)
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 20 November 2024
First Online: 28 November 2024
Declarations
:
: This study was approved by the Ethics Committee of Guangzhou First people's Hospital (Approval No.: K-2021–008-01, and approval date: January 17, 2022.) to use umbilical cord blood and human platelets from healthy volunteers for Large-scale Preparation of Functional Platelets from hESCs/iPSCs. The patients or their guardians/legally authorized representatives provided written informed consent for participation in the study with the use of umbilical cord blood and human platelets. All mouse experiments were performed according to our experimental protocols approved by the Guangzhou Committee for the Use and Care of Laboratory Animals, and by the Animal Ethics Committee of South China University of Technology University (Approval number: 2019073, and approval date: December 12, 2019.). WiCell Research Institute has confirmed that there was the ethical approval for collection of human embryonic stem cells (WA01(H1) and WA09(H9)) with NIH Approval NIHhESC-10–0043 and NIH Approval NIHhESC-10–0062, and that the donors had signed informed consent ().
: The authors declare that there is no competing interests.
